Editorial Board Member
Pele Choi-Sing Chong
Vaccine Research and Development Center, National Health Research Institutes, Taiwan
About
As published by the journal they serve.
Dr. Chong is Distinguished Investigator and Director, Vaccine Research and Development Center at National Health Research Institutes, Taiwan. Dr. Chong had spent 15 years at Aventis Pasteur in human vaccine research and development. During his tenure there, Dr. Chong had developed two human vaccines, ProHibit against H. influenzae type b and the component pertussis vaccine, and also took a synthetic peptide-based HIV vaccine to phase I clinical trials in 1994. In June 2000, Dr. Chong joined United Biomedical, Inc. (UBI) as the Vice President and assisted to develop a peptide-based Foot-Mouth Disease vaccine. In 2003, Dr. Chong joined National Health Research Institutes (NHRI) to set up a newly created Vaccine Center for Research and Development. Dr. Chong has authored over 80 original research articles and over 40 patents grants.
Research interests
Journals they serve
The seats these journals name them in.
- La Prensa MedicaEditorial Board Member
Articles we hold
Articles in the journals they serve whose byline carries this name.
No article in our collection carries this name on its byline. Not every article names its authors in a way that can be matched, so this is not a list of everything they have written.
This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.